PremiumCompany AnnouncementsGenScript Announces Legend Biotech’s Q1 2025 Financial Results Genscript Biotech Completes Major Share Transfer in Probio Cayman Genscript Biotech Increases Stake in Probio Cayman with $225 Million Share Purchase PremiumCompany AnnouncementsGenscript Biotech Reports Significant Profit Boost from Cell Therapy Deconsolidation Genscript Biotech Announces Legend Biotech’s 2024 Financial Results Genscript Biotech Redesignates Dr. Grossman as Independent Director PremiumCompany AnnouncementsGenscript Biotech Enhances Risk Management with New Sub-Committee Legend Biotech Reports Strong CARVYKTI® Sales for Q4 2024 Genscript Biotech Boosts Stake in Probio Cayman